Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

AGRN Protein (AA 1856-2045) (His tag)

AGRN Origin: Human Host: Escherichia coli (E. coli) Recombinant > 90 % SDS, WB, Imm, PC
Catalog No. ABIN7393733
  • Target See all AGRN Proteins
    AGRN (Agrin (AGRN))
    Protein Type
    Recombinant
    Protein Characteristics
    AA 1856-2045
    Origin
    • 5
    • 5
    • 1
    Human
    Source
    • 7
    • 4
    Escherichia coli (E. coli)
    Purification tag / Conjugate
    This AGRN protein is labelled with His tag.
    Application
    SDS-PAGE (SDS), Western Blotting (WB), Immunogen (Imm), Positive Control (PC)
    Sequence
    Leu1856-Pro2045
    Characteristics
    Recombinant Agrin (AGRN), Prokaryotic expression, Leu1856-Pro2045, N-terminal His Tag
    Purity
    > 90 %
    Top Product
    Discover our top product AGRN Protein
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Comment

    Isoelectric Point:6.2

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Buffer
    100 mMNaHCO3, 500 mMNaCl, pH 8.3, containing 1 mM EDTA, 1 mM DTT, 0.01 % SKL, 5 % Trehalose and Proclin300.
    Preservative
    ProClin
    Precaution of Use
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C,-80 °C
    Storage Comment
    Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
    Expiry Date
    12 months
  • Target
    AGRN (Agrin (AGRN))
    Alternative Name
    Agrin (AGRN Products)
    Synonyms
    AGRIN Protein, agrn Protein, wu:fb57e07 Protein, Agrin Protein, nmf380 Protein, AGR Protein, HSPG Protein, agrin Protein, LOC465392 Protein, agrn Protein, AGRN Protein, Agrn Protein
    Background
    Agrin Proteoglycan
    Molecular Weight
    27kDa
    UniProt
    O00468
    Pathways
    Glycosaminoglycan Metabolic Process, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development
You are here: